Kalyoncu, U. Et Al. 2021. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4 , 1615-1623.

Kalyoncu, U., Pehlivan, Y., Akar, S., Kaşifoğlu, T., Kimyon, G., Karadağ, Ö., ... Dalkılıç, H. E.(2021). Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, 1615-1623.

Kalyoncu, Umut Et Al. "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, 1615-1623, 2021

Kalyoncu, Umut Et Al. "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1615-1623, 2021

Kalyoncu, U. Et Al. (2021) . "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1615-1623.

@article{article, author={Umut Kalyoncu Et Al. }, title={Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2021, pages={1615-1623} }